Tempus AI (NASDAQ:TEM) Now Covered by Morgan Stanley

Stock analysts at Morgan Stanley started coverage on shares of Tempus AI (NASDAQ:TEMGet Free Report) in a research note issued on Tuesday, MarketBeat Ratings reports. The firm set an “overweight” rating and a $44.00 price target on the stock. Morgan Stanley’s target price suggests a potential upside of 25.71% from the company’s current price.

A number of other equities analysts also recently commented on the company. Loop Capital began coverage on Tempus AI in a report on Tuesday. They issued a “buy” rating and a $48.00 price objective on the stock. Needham & Company LLC initiated coverage on shares of Tempus AI in a report on Tuesday. They issued a “buy” rating and a $47.00 price target on the stock. JPMorgan Chase & Co. started coverage on shares of Tempus AI in a research note on Tuesday. They set an “overweight” rating and a $42.00 price objective for the company. Stifel Nicolaus assumed coverage on shares of Tempus AI in a research note on Tuesday. They issued a “buy” rating and a $45.00 target price on the stock. Finally, TD Cowen started coverage on Tempus AI in a research report on Tuesday. They issued a “buy” rating and a $50.00 price objective on the stock. Nine equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $45.63.

View Our Latest Research Report on Tempus AI

Tempus AI Price Performance

Tempus AI stock opened at $35.00 on Tuesday. Tempus AI has a 1 year low of $22.89 and a 1 year high of $43.88.

About Tempus AI

(Get Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

See Also

Analyst Recommendations for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.